TJ
Tobin W Juvenal (Chief Commercial Officer) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Castle Biosciences, Inc. (CSTL). The largest single filing was $527K of CSTL (20,863 sh × $25.24, as filed), executed Mar 12. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
10
0 buys · 10 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.6M
shares × price, as filed
Last traded
Oct 28
Filed Oct 30
Median ADV $11.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
CSTLRecent filings
CSTLSALE
Castle Biosciences, Inc.
View filing →
$495K13,200 sh × $37.48
Exec Dec 11 2025
Filed Dec 15 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $167K
4,693 sh × $35.58
Exec Nov 20 2025
Filed Nov 24 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $125K
3,507 sh × $35.56
Exec Nov 5 2024
Filed Nov 7 2024 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $110K
3,100 sh × $35.39
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET